Immunological studies in chronic mucocutaneous candidiasis before and after ketoconazole treatment.
Immune functions were studied in eight patients with chronic mucocutaneous candidiasis representing a broad clinical spectrum of this disease. Clinical improvement after ketoconazole for 6 months was not associated with amelioration of cutaneous delayed hypersensitivity to Candida antigen or the in vitro lymphocyte responses to Candida antigen of T-cell mitogens.